Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1

Conditions

Fibrosis 2Stomatitis 1Small Cell Lung Carcinoma 1Lymphedema 1Lung Neoplasms 1Head and Neck Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Pentoxifylline 3Tocopherols 2tremelimumab 1ruxolitinib 1maltodextrin 1durvalumab 1atezolizumab 1Vitamin E 1Sunitinib 1Standard of Care 1Specimen Handling 1Simvastatin 1Pravastatin 1Physical Therapy Modalities 1Pharmaceutical Preparations 1Magnetic Resonance Spectroscopy 1Losartan 1Liver Transplantation 1Ketoprofen 1Hyperbaric Oxygenation 1Bevacizumab 1Amino Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Fibrosis × Tocopherols × Clear all
NCT06912763 2026-01-26

Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

M.D. Anderson Cancer Center

Phase 2 Recruiting
250 enrolled
Head & Neck

Fibrosis, Head and Neck Neoplasms, Lymphedema

NCT01822405 2013-04-02

ORT-OXI-2009

Hospital Universitario de Canarias

Phase 2 Unknown
42 enrolled

Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡